As the CTL response plays a major role in tumor immunity elicited by gp96–tumor Ag complexes, we examined the effect of immunization with wild type or mutant gp96 on tumor rejection as a direct in vivo read-out of the CTL activity induced by gp96. This evidence concerns the gene HSP90B1 and neoplasm.